Serina Therapeutics Inc (SER)
NYSEAMERICAN: SER · IEX Real-Time Price · USD
9.71
+0.87 (9.84%)
At close: Jul 19, 2024, 4:00 PM
9.66
-0.05 (-0.51%)
After-hours: Jul 20, 2024, 12:58 PM EDT

Serina Therapeutics Revenue

Serina Therapeutics had revenue of $3.15M in the twelve months ending March 31, 2024, with 410.71% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.00K. In the year 2023, Serina Therapeutics had annual revenue of $3.15M with 433.14% growth.

Revenue (ttm)
$3.15M
Revenue Growth
+410.71%
P/S Ratio
25.95
Revenue / Employee
$286,227
Employees
11
Market Cap
81.70M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.15M2.56M433.14%
Dec 31, 2022591.50K447.50K310.76%
Dec 31, 2021144.00K-217.00K-60.11%
Dec 31, 2020361.00K-1.37M-79.11%
Dec 31, 20191.73M332.00K23.78%
Dec 31, 20181.40M-8.00K-0.57%
Dec 31, 20171.40M-262.00K-15.73%
Dec 31, 20161.67M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SCYNEXIS 140.39M
Protalix BioTherapeutics 59.65M
Sangamo Therapeutics 18.76M
DBV Technologies 14.94M
Chimerix 41.00K
Revenue Rankings